{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:17Z","timestamp":1789628537014,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.eprac.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T22:20:36Z","timestamp":1656541236000},"page":"901-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypophysitis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5091-9582","authenticated-orcid":false,"given":"Diane","family":"Donegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2022.06.009_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.eprac.2022.06.009_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.tem.2019.06.004","article-title":"The changing clinical spectrum of hypophysitis","volume":"30","author":"Chiloiro","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2022.06.009_bib3","first-page":"2302","article-title":"Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings","volume":"80","author":"Thodou","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2022.06.009_bib4","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1210\/jc.2012-2269","article-title":"Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells","volume":"97","author":"De Bellis","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.20945\/2359-3997000000102","article-title":"Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience","volume":"63","author":"Imga","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/clinem\/dgab839","article-title":"Outcomes of initial management strategies in patients with autoimmune lymphocytic hypophysitis: a systematic review and meta-analysis","volume":"107","author":"Donegan","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02739954","article-title":"Lymphocytic hypophysitis: light and electron microscopic findings and correlation to clinical appearance","volume":"9","author":"Fehn","year":"1998","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.eprac.2022.06.009_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.pas.0000149707.12335.8e","article-title":"Immunopathology of primary hypophysitis: implications for pathogenesis","volume":"29","author":"Gutenberg","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.eprac.2022.06.009_bib9","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/en.2007-1692","article-title":"Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model","volume":"149","author":"Tzou","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jcem.87.2.8205","article-title":"Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase","volume":"87","author":"O\u2019Dwyer","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2265.2008.03180.x","article-title":"Novel autoantigens in autoimmune hypophysitis","volume":"69","author":"Lupi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2022.06.009_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-11-1015","article-title":"Identification of TPIT and other novel autoantigens in lymphocytic hypophysitis: immunoscreening of a pituitary cDNA library and development of immunoprecipitation assays","volume":"166","author":"Smith","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.06.009_bib13","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1210\/jc.2014-4209","article-title":"Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis","volume":"100","author":"Iwama","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2022.06.009_bib14","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1210\/jc.2015-2702","article-title":"HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis","volume":"100","author":"Heaney","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2022.06.009_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/cen.13566","article-title":"Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in Caucasian patients","volume":"88","author":"Chiloiro","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.eprac.2022.06.009_bib16","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.ajpath.2016.08.020","article-title":"Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: insights into pathogenesis from an autopsy series","volume":"186","author":"Caturegli","year":"2016","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.eprac.2022.06.009_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/a-1163-7304","article-title":"Clinical characteristics of primary hypophysitis\u2013a single-centre series of 60 cases","volume":"129","author":"Amereller","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11102-013-0550-9","article-title":"Primary (autoimmune) hypophysitis: a single centre experience","volume":"18","author":"Khare","year":"2015","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/a-0919-4388","article-title":"Primary hypophysitis: experience of a single tertiary center","volume":"129","author":"Korkmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11102-016-0769-3","article-title":"Lymphocytic hypophysitis: modern day management with limited role for surgery","volume":"20","author":"Kyriacou","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000516006","article-title":"Early pulse glucocorticoid therapy and improved hormonal outcomes in primary hypophysitis","volume":"112","author":"Krishnappa","year":"2022","journal-title":"Neuroendocrinology"},{"issue":"10","key":"10.1016\/j.eprac.2022.06.009_bib22","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1210\/jc.2015-2152","article-title":"Diagnosis of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2022.06.009_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11102-014-0622-5","article-title":"Hypophysitis: a single-center case series","volume":"18","author":"Imber","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-17-0123","article-title":"Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis","volume":"177","author":"Lupi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/a-1113-7777","article-title":"Clinical characteristics, management, and treatment outcomes of primary hypophysitis: a monocentric cohort","volume":"52","author":"Oguz","year":"2020","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.13354","article-title":"Primary lymphocytic hypophysitis: clinical characteristics and treatment of 50 cases in a single centre in China over 18 years","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/cen.13362","article-title":"Clinical presentation and outcome of children with central diabetes insipidus associated with a self-limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis","volume":"87","author":"Schaefers","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11102-018-0892-4","article-title":"Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis","volume":"21","author":"Tartaglione","year":"2018","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12020-021-02612-5","article-title":"Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study","volume":"73","author":"Chiloiro","year":"2021","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.eprac.2022.06.009_bib30","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3174\/ajnr.A1714","article-title":"A\u00a0radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively","volume":"30","author":"Gutenberg","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.eprac.2022.06.009_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jnnp.67.3.398","article-title":"Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy?","volume":"67","author":"Kristof","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.eprac.2022.06.009_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","article-title":"Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects","volume":"19","author":"Bellastella","year":"2016","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.eprac.2022.06.009_bib33","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/0028-3886.227293","article-title":"Corticosteroids in the management of lymphocytic hypophysitis: case series","volume":"66","author":"Panigrahi","year":"2018","journal-title":"Neurol India"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s701-002-8273-5","article-title":"Inflammatory hypophysitis\u2013the spectrum of disease","volume":"144","author":"Flanagan","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib36","first-page":"262","article-title":"Primary hypophysitis: a single-center experience in 16 cases","volume":"101","author":"Leung","year":"2004","journal-title":"J\u00a0Neurosurg"},{"issue":"9","key":"10.1016\/j.eprac.2022.06.009_bib37","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1210\/jc.2015-2146","article-title":"Treatment of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2022.06.009_bib38","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/j.wneu.2019.01.250","article-title":"Clinical features, magnetic resonance imaging, and treatment experience of 20 patients with lymphocytic hypophysitis in a single center","volume":"127","author":"Zhu","year":"2019","journal-title":"World Neurosurg"},{"issue":"10","key":"10.1016\/j.eprac.2022.06.009_bib39","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2018-01021","article-title":"Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study","volume":"103","author":"Chiloiro","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3803\/EnM.2014.29.4.470","article-title":"Clinical characteristics, management, and outcome of 22 cases of primary hypophysitis","volume":"29","author":"Park","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0044-101036","article-title":"Clinical, endocrine and imaging characteristics of patients with primary hypophysitis","volume":"50","author":"Angelousi","year":"2018","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0037-1604079","article-title":"Lymphocytic hypophysitis successfully treated with stereotactic radiosurgery: case report and review of the literature","volume":"79","author":"Pekic","year":"2018","journal-title":"J\u00a0Neurol Surg A Cent Eur Neurosurg"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s13256-021-03146-0","article-title":"Recurrent autoimmune hypophysitis treated with rituximab: a case report","volume":"15","author":"Kruse","year":"2021","journal-title":"J\u00a0Med Case Rep"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11102-019-01005-2","article-title":"Granulomatous hypophysitis causing compression of the internal carotid arteries reversible with azathioprine and rituximab treatment","volume":"23","author":"Gendreitzig","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/eje.1.02183","article-title":"Primary hypophysitis: clinical-pathological correlations","volume":"155","author":"Gutenberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11102-013-0510-4","article-title":"Idiopathic granulomatous hypophysitis: a systematic review of 82 cases in the literature","volume":"17","author":"Hunn","year":"2014","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.eprac.2022.06.009_bib47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/apm.12603","article-title":"Granulomatous and lymphocytic hypophysitis\u2013are they immunologically distinct?","volume":"124","author":"Rao","year":"2016","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2022.06.009_bib49","article-title":"Hypophyseal involvement in immunoglobulin G4-related disease: a retrospective study from a single tertiary center","volume":"2018","author":"Liu","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12020-021-02714-0","article-title":"IgG4-related hypophysitis","volume":"73","author":"Amirbaigloo","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.eprac.2022.06.009_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bpa.12459","article-title":"IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis","volume":"27","author":"Bernreuther","year":"2017","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.eprac.2022.06.009_bib52","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5414\/NP300841","article-title":"The prevalence of IgG4-positive plasma cells in hypophysitis: a possible relationship to IgG4-related disease","volume":"34","author":"Tauziede-Espariat","year":"2015","journal-title":"Clin Neuropathol"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1507\/endocrj.EJ19-0569","article-title":"Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society","volume":"67","author":"Takagi","year":"2020","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.eprac.2022.06.009_bib55","doi-asserted-by":"crossref","first-page":"bvaa048","DOI":"10.1210\/jendso\/bvaa048","article-title":"A\u00a0case series of patients with isolated IgG4-related hypophysitis treated with rituximab","volume":"4","author":"Boharoon","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.eprac.2022.06.009_bib56","article-title":"Xanthomatous hypophysitis: a case report and comprehensive literature review","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12022-017-9471-x","article-title":"Xanthomatous hypophysitis is associated with ruptured Rathke\u2019s cleft cyst","volume":"28","author":"Duan","year":"2017","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.eprac.2022.06.009_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/17446651.2019.1701434","article-title":"Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment","volume":"14","author":"Di Dalmazi","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2022.06.009_bib60","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2014-2306","article-title":"Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma","volume":"99","author":"Faje","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","article-title":"Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights","volume":"19","author":"Faje","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.eprac.2022.06.009_bib62","article-title":"Immune-related adverse events associated with outcomes in patients with NSCLC treated with anti-PD-1 inhibitors: a systematic review and meta-analysis","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11102-021-01182-z","article-title":"Differences between immunotherapy-induced and primary hypophysitis-a multicenter retrospective study","volume":"25","author":"Amereller","year":"2022","journal-title":"Pituitary"},{"issue":"17","key":"10.1016\/j.eprac.2022.06.009_bib64","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2022.06.009_bib65","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1078-0432.CCR-14-2353","article-title":"Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study","volume":"21","author":"Min","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.eprac.2022.06.009_bib66","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/cncr.31629","article-title":"High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma","volume":"124","author":"Faje","year":"2018","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.eprac.2022.06.009_bib67","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.eprac.2022.06.009_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/ERC-20-0513","article-title":"Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns","volume":"28","author":"Nguyen","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.eprac.2022.06.009_bib69","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.eprac.2022.04.010","article-title":"American Association of Clinical Endocrinology (AACE) disease state clinical review evaluation and management of immune checkpoint inhibitor-mediated endocrinopathies: a practical case-based clinical approach","volume":"28","author":"Yuen","year":"2022","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2022.06.009_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI44073","article-title":"Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans","volume":"121","author":"Yamamoto","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.eprac.2022.06.009_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22005444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22005444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:25Z","timestamp":1761516805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22005444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1530891X22005444"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.06.009","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypophysitis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}